Journal List > Korean J Obstet Gynecol > v.53(3) > 1006387

Park, Choi, Son, Jeong, Kim, Byun, Kim, Jeong, Jeong, Lee, Sung, and Kim: A study on clinicopathological characteristics of ovarian masses

Abstract

Objective

The aim of this study was to know the clinicopathological characteristics that help to make a decision about diagnosis and treatment of ovarian masses in Korean women.

Methods

Women who were undergone operations and histopathologically confirmed as ovarian masses at Inje University Busan Paik Hospital and Donrae Paik Hospital from January of 1997 to June of 2009 were enrolled in this study. Distribution according to histopathological types and ages were analyzed.

Results

Of the 2875 cases, there were 1078 cases (37.5%) of non neoplastic masses and 1797 cases (62.5%) of neoplastic masses. In the neoplatic masses, there were 1286 cases (44.7%) of benign tumors, 140 cases (4.9%) of borderline tumors and 371 cases (12.9%) of malignant tumors. Endometriomas were most common tumors (644 cases, 59.7%) among non-neoplastic masses. Mature cystic teratomas were the most common tumors (598 cases, 46.5%) among benign tumors. Mucinous cystadenomas were the most common types (105 cases, 75.0%) among borderline tumors. Epithelial ovarian cancers were the most common types (267 cases, 72.0%) among malignant tumors. As the result of age distribution, mature cystic teratomas were the most common types of the women of the first and second decade, endometriomas were the most common types of the women of the third and fourth decade, and benign epithelial tumors were the most common types of the women of fifth and after sixth decade.

Conclusion

Taken as a whole, neoplastic ovarian masses were more common than non-neoplastic masses, but most common ovarian mass was endometrioma which is non-neoplastic mass.

Figures and Tables

Table 1
Distribution of ovarian mass by 3 yearly
kjog-53-235-i001
Table 2
Distribution of ovarian mass according to histopathologic types
kjog-53-235-i002
Table 3
Age distribution of patients with ovarian mass
kjog-53-235-i003

References

1. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004. 110:155–169.
crossref
4. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999. 49:33–64. –1.
crossref
7. Shin HR, Jung KW, Won YJ, Park JG. 139 KCCR-affiliated Hospitals. 2002 Annual report of the Korean Center Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat. 2004. 36:103–114.
16. Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer. 2006. 94:1586–1591.
crossref
23. Kozlowski KJ. Ovarian masses. Adolesc Med. 1999. 10:337–350. vii.
24. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol. 1989. 74:921–926.
crossref
25. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study fo 65 advaced stage cases. Am J Surg Pathol. 1996. 20:1331–1345.
TOOLS
Similar articles